Corrigendum: Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reports(Front. Oncol., (2022), 12, (1000099), 10.3389/fonc.2022.1000099)

0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

In the published article, there was an error in affiliation 1. Instead of “Department of Dermatology, Children’s Hospital of Chongqing Medical University, Chongqing, China” it should be “Department of Dermatology, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing, China”. In the published article, there was an error in affiliation 4. Instead of “AMITA Health Saini Joseph Hospital Chicago, University of lllinois at Chicago, Chicago, IL, United States” it should be “AMITA Health Saint Joseph Hospital Chicago, University of Illinois at Chicago, Chicago, IL, United States”. The authors apologize for these errors and state that these do not change the scientific conclusions of the article in any way. The original article has been updated.

Cite

CITATION STYLE

APA

Chen, Q., Zhang, Y., Sun, C., Liu, L., Luo, X., Wang, H., & Ni, S. (2023). Corrigendum: Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reports(Front. Oncol., (2022), 12, (1000099), 10.3389/fonc.2022.1000099). Frontiers in Oncology. Frontiers Media SA. https://doi.org/10.3389/fonc.2023.1282607

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free